| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/25/1997 | US5614384 Hepatitis B virus surface proteins with reduced host carbohydrate content |
| 03/25/1997 | US5614382 Plasmid for production of CRM protein and diphtheria toxin |
| 03/25/1997 | US5614381 Method for the inducible production of proteins in genetically modified eukaryotic host-cells multiplied in vivo |
| 03/25/1997 | US5614367 Diagnostic test using chimeric antibodies |
| 03/25/1997 | US5614366 HTLV-I peptide antigens and kit |
| 03/25/1997 | US5614365 DNA polymerase having modified nucleotide binding site for DNA sequencing |
| 03/25/1997 | US5614195 Coccidiosis poultry vaccine |
| 03/25/1997 | US5614191 Antitumor |
| 03/25/1997 | US5614190 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 03/25/1997 | US5614189 Recombinantly produced lipases for therapeutical treatment |
| 03/25/1997 | US5614187 Conferring tolerance to foreign tissue in recipient mammal |
| 03/25/1997 | US5614185 Compositions containing reduced, microbially produced interleukin-2 (IL-2) |
| 03/25/1997 | US5614184 Recombinant human erythropoietin mutants and therapeutic methods employing them |
| 03/25/1997 | US5614183 Use of CSF-1 to treat bacterial infections |
| 03/25/1997 | CA2050479C Cd3 specific recombinant antibody |
| 03/25/1997 | CA1339014C Antibodies to a4 amyloid peptide |
| 03/25/1997 | CA1339013C Cross-protective human monoclonal antibody compositions |
| 03/25/1997 | CA1339012C Dna-molecules coding for fmdh (formate dehydrogenase) control regions and structured gene for a protein having fmdh-activity and their uses |
| 03/25/1997 | CA1339011C Dna fragment having the cyclodextrin glycosyltransferase structural gene, an expression vector and microorganims for the expression of said gene, and a process for the preparationof same |
| 03/25/1997 | CA1339010C Oligonucleotide polymeric support system |
| 03/20/1997 | WO1997010507A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 03/20/1997 | WO1997010505A1 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc¿ |
| 03/20/1997 | WO1997010365A1 Expression monitoring by hybridization to high density oligonucleotide arrays |
| 03/20/1997 | WO1997010364A1 Continuous amplification reaction |
| 03/20/1997 | WO1997010363A1 Method for serial analysis of gene expression |
| 03/20/1997 | WO1997010362A1 Methods of using nucleotide integrase for cleaving dna and attaching nucleic acids |
| 03/20/1997 | WO1997010361A1 Method for modulating cell apoptosis |
| 03/20/1997 | WO1997010360A1 Method and construct for screening for inhibitors of transcriptional activation |
| 03/20/1997 | WO1997010359A1 Method for concentrating variant nucleic acid and nucleic acid concentration test kit for effecting the method |
| 03/20/1997 | WO1997010353A1 Production of lysosomal enzymes in plant-based expression systems |
| 03/20/1997 | WO1997010349A1 Materials and methods for treating neurodegenerative diseases and for screening for candidate apoptosis inhibitors and inducers |
| 03/20/1997 | WO1997010347A1 Expression cassettes and methods for delivery of animal vaccines |
| 03/20/1997 | WO1997010346A2 Removal of metals from contaminated substrates by plants |
| 03/20/1997 | WO1997010345A1 Promoter/terminator of formate dehydrogenase gene of candida boidinii |
| 03/20/1997 | WO1997010344A1 Genetically engineered yeast strains |
| 03/20/1997 | WO1997010343A1 Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 03/20/1997 | WO1997010342A1 Alkaliphilic and thermophilic microorganisms and enzymes obtained therefrom |
| 03/20/1997 | WO1997010341A1 D-pantolactone hydrolase and gene encoding the same |
| 03/20/1997 | WO1997010340A1 Process for producing d-pantoic acid and d-pantothenic acid or salts thereof |
| 03/20/1997 | WO1997010339A1 Flowering genes |
| 03/20/1997 | WO1997010338A1 Improved interleukin-6 receptor antagonist |
| 03/20/1997 | WO1997010337A1 Steroid receptor coactivator compositions and methods of use |
| 03/20/1997 | WO1997010336A1 A kinase anchoring protein and uses thereof |
| 03/20/1997 | WO1997010335A1 Recombinant polypeptide based on the primary sequence of the invariant chain with at least one primary sequence of a specific t-cell epitope or a protein derivative and nucleic acids coding for this recombinant polypeptide |
| 03/20/1997 | WO1997010334A2 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 03/20/1997 | WO1997010332A2 Chimaeric oligonucleotides and uses thereof in the identification of antisense binding sites |
| 03/20/1997 | WO1997010331A1 Method for purifying nucleic acids from homogeneous mixtures |
| 03/20/1997 | WO1997010330A1 Combined ligand and receptor display |
| 03/20/1997 | WO1997010329A1 Neural transplantation using pluripotent neuroepithelial cells |
| 03/20/1997 | WO1997010328A2 Compositions and method for modulation of gene expression in plants |
| 03/20/1997 | WO1997010258A2 Antibodies against epitopes, exposed on surfaces of cancer cells outside desmosomes, of desmosomal cadherines |
| 03/20/1997 | WO1997010254A1 Oligomers which inhibit expression of collagen genes |
| 03/20/1997 | WO1997010253A1 A high throughput assay using fusion proteins |
| 03/20/1997 | WO1997010249A1 Toxoplasma gondii glycoconjugates |
| 03/20/1997 | WO1997010056A2 Device and method for dna amplification and assay |
| 03/20/1997 | WO1997010006A1 Method for inhibiting cell-mediated killing of target cells |
| 03/20/1997 | WO1997009998A2 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | WO1997009994A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/20/1997 | WO1997007235A3 All-in-one nucleic acid amplification assay |
| 03/20/1997 | WO1997007220A3 Linker insertion mutagenesis by means of the transposition system of insertion sequence is21 |
| 03/20/1997 | WO1997004114A3 Isolated dna sequence for use as a regulator region in a chimeric gene useful for transforming plants |
| 03/20/1997 | WO1997004103A3 Mutated 5-enol pyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene |
| 03/20/1997 | WO1997003204A3 (s)-hydroxynitrillyase from hevea brasiliensis |
| 03/20/1997 | WO1997003187A3 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 03/20/1997 | WO1997000952A3 A human edg-2 receptor homolog |
| 03/20/1997 | WO1996033271A3 Genetic markers for breast and ovarian cancer |
| 03/20/1997 | WO1996025498A3 Mpl ligand analogs |
| 03/20/1997 | DE19535853A1 Varianten des humanen rekombinanten Interferon-gamma (rhu-IFN-gamma) mit erhöhter thermischer Stabilität Variants of the human recombinant interferon-gamma (rhu-IFN-gamma) with increased thermal stability |
| 03/20/1997 | DE19534759A1 DNA coding for starch-binding protein |
| 03/20/1997 | DE19534579A1 Nucleinsäure-Moleküle codierend Proteine, die die Adhäsion von Neisseria-Zellen an humane Zellen vermitteln Nucleic acid molecules encoding proteins which mediate the adhesion of Neisseria cells to human cells |
| 03/20/1997 | CA2304945A1 Device and method for dna amplification and assay |
| 03/20/1997 | CA2232089A1 Oligomers which inhibit expression of collagen genes |
| 03/20/1997 | CA2232047A1 Expression monitoring by hybridization to high density oligonucleotide arrays |
| 03/20/1997 | CA2232033A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/20/1997 | CA2232023A1 Expression cassettes and methods for delivery of animal vaccines |
| 03/20/1997 | CA2232012A1 Toxoplasma gondii glycoconjugates |
| 03/20/1997 | CA2232000A1 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | CA2231861A1 Method for concentrating mutant nucleic acid and nucleic acid-concentrating assay kit for said concentration method |
| 03/20/1997 | CA2231850A1 Steroid receptor coactivator compositions and methods of use |
| 03/20/1997 | CA2231843A1 Alkaliphilic and thermophilic microorganisms and enzymes obtained therefrom |
| 03/20/1997 | CA2231804A1 Method for inhibiting cell-mediated killing of target cells |
| 03/20/1997 | CA2231685A1 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 03/20/1997 | CA2231433A1 Method for modulating cell apoptosis |
| 03/20/1997 | CA2231423A1 Cytoplasmic male sterile brassica oleracea plants which contain the polima cms cytoplasm and are male sterile at high and low temperatures |
| 03/20/1997 | CA2231330A1 A high throughput assay using fusion proteins |
| 03/20/1997 | CA2230483A1 Combined ligand and receptor display |
| 03/20/1997 | CA2229307A1 Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 03/20/1997 | CA2226728A1 Compositions and method for modulation of gene expression in plants |
| 03/20/1997 | CA2205234A1 High throughput screening method for sequences or genetic alterations in nucleic acids |
| 03/19/1997 | EP0763601A2 Homogeneous hybridization assay with label specific receptors |
| 03/19/1997 | EP0763599A2 DNA encoding thermostable pyrophosphatase |
| 03/19/1997 | EP0763598A1 Method of preparing a fusion protein |
| 03/19/1997 | EP0763597A2 Use of cytohesin-PH peptides to influence the adhesion capability of integrins |
| 03/19/1997 | EP0763543A2 A method for preparing an inflammatory cytokine (MIP-2) and diagnostic and therapeutic applications for the cytokine or its antibody |
| 03/19/1997 | EP0763542A2 Long-chain prenyl diphosphate synthase |
| 03/19/1997 | EP0763205A1 Nucleic acid sequences controlling lung cell-specific gene expression |
| 03/19/1997 | EP0763136A1 Method and probes for detecting markers bound to the locus of child spinal muscular atrophies |
| 03/19/1997 | EP0763135A1 Producing copies of nucleic acids |
| 03/19/1997 | EP0763134A2 Materials and methods for the detection of mycobacteria |
| 03/19/1997 | EP0763133A1 Method for detecting a target nucleic acid |